BullSticks

[charthawk]

stalking WZEN for bottom entry, korea stock, big selloff as of late due to korean markets, probably risky play

[charthawk]

man GIGM strong, ran away from me, hoping for nice healthy dip again...grrrr

[charthawk]

watching GIGM intraday for entry, something is up there looks like

[charthawk]

in WTSLA 4.75, 15/20 play and swing trade on that upgrade today, and bottom chart

[charthawk]

also following GNTA closely, if it can break 1.96 will have a nice little move

[charthawk]

was concentrating so much on daytrading otc's that I've neglected this board, will be swing trading more larger cap stuff this summer

[charthawk]

also SIFY is one I've been concentrating on, i belive it should go over 11 again in the short term, but i have been trading it's current channel right now, if it can ever break 10.50 area should move nicely i think

[charthawk]

playing DESC swing trade for this coming week

[Handles]

thanks Nate....I told you to watch that stock.....much more to come from what i hear....lots of news around the corner is what I am guessing......

[charthawk]

nice chart for sure, the spread has kept me from trading it, but it's been a nice hold for sure

[Handles]

VPRO another beauty with major legs.....volume about to get crazy and then watch it gap hard....

[charthawk]

another one that crapped out today, looks like you have to stick with momo stocks nowadays

[charthawk]

acmg, got hammered on that one, grrrr

[charthawk]

HYFS, another frustarting one, needs to hold above 15ema

[charthawk]

ABZT, black candle worries me, so i sold today, will reenter depending on tommorrow's candle, or if it dips to support or breaks that .34 top this morning, was strange had alot of trades go off .33, .34 early this morning but did nothing

[charthawk]

another naz pos, these are frustrating me latley, stock breaks out, and then sells off, makes no sense

[charthawk]

accumulating AMEP under .11 also for the run @ cup and handle breakout

[charthawk]

ACMG chart

[charthawk]

in MCDG, here .225 is breakout, sweet chart

[charthawk]

got ACMG .17-.18 today

Alcar Chemicals Group's Proprietary EnviroEnergy Technology Receives Independent Evaluation at $85 Million USD
Alcar Chemical Group Inc. (OTC: ACMG) announces today the completion of an independent evaluation of its proprietary technology to produce plastic raw materials, Ethanol and Bio-Diesel based on renewable resources. The independent evaluation was performed by CLD and they have established the value at $85 million USD, translating into approximately $0.90 per share on a fully diluted basis.

"ACMG's proprietary technology represents today's most economical and advanced manufacturing process for plastic raw materials, ethanol and bio-diesel," said Alexander Cavasin, President and CEO of ACMG. "The yield output of our process alone will create immediate impact in our industry and we expect many more large multi-nationals to be adopting and licensing our technology over the coming months," further added Mr. Cavasin.

The proprietary technology developed by ACMG is a process, based on renewable natural resources, where it can use inexpensive non-food-crop and generic organic waste as feedstock, to produce plastic raw materials, ethanol and bio-diesel. ACMG's Process significantly reduces production cost and obtains yield rates that are significantly higher than the industry standard.

About The Alcar Group

The Alcar Group represents a significant market opportunity due to a serious worldwide supply shortage of raw materials for polymers, a growing shortage estimated to reach over 6 million tons in 2006. The market price for the materials in question vary between $1,000 and $3,000 per metric ton and the Alcar Group has developed a patented process and bioreactor which allow production at costs savings of up to 40% when compared to current production methods, translating in gross margins of over 50%. With the planned expansion, the AGI production process will reach a total capacity of 120,000 tons annually of economical and environmentally friendly materials for polymers.

The Alcar Group Inc. (AGI) develops innovative, patented methods for petroleum-independent fuel and plastics resin production (e.g. polyurethane) that significantly improve the offerings of its customers in the automotive, building products and recreational sectors. AGI operates three divisions, Alcar Advanced Materials Corp., which manufactures and distributes various proprietary non-petroleum-based plastics and coating systems, Alcar Advanced Energy Systems Corp., which will manufacture and distribute high-purity non-petroleum-based ethanol and diesel fuels and Alcar R&D, an advanced materials research and development center.

Important Information About Forward-Looking Statements

All statements in this news release that are other than statements of historical facts are forward-looking statements, which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties. We have attempted to identify any forward-looking statements by using words such as "anticipates," "believes," "could," "expects," "intends," "may," "should" and other similar expressions. Although we believe that the expectations reflected in all of our forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.

A number of factors may affect our future results and may cause those results to differ materially from those indicated in any forward-looking statements made by us or on our behalf. Such factors include our limited operating history; our need for significant capital to finance internal growth as well as strategic acquisitions; our ability to attract and retain key employees and strategic partners; our ability to achieve and maintain profitability; fluctuations in the trading price and volume of our stock; competition from other providers of similar products and services; and other unanticipated future events and conditions.



Source: Market Wire (April 20, 2006 - 9:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

[charthawk]

just gonna hold HYFS and wait this dip out, friday selloff, now panicing bidwhackers

[charthawk]

in IPAS, breakout chart, hold into monday, will accumulate under 8.45

[charthawk]

HYFS, could see nice steady uptrend, .50 is first res. test

[charthawk]

ABZT broke late yesterday, .40 is our first res. area

[charthawk]

out HGSI, falling,,,grrrr

[charthawk]

in HGSI 11.56-11.59 for overnighter up big on rumors today

[charthawk]

in ABZT, .26, .27 is break, this company just had great earnings on the 17th, trading way low here, coming off double bottom support area, could be good short term also http://biz.yahoo.com/bw/060417/20060417005345.html?.v=1

[charthawk]

HYFS, accumulating

[charthawk]

trading PBLS, AMHD, SLGLF, and QOIL, gonna hold them all into tomm., so far i like what i see

[charthawk]

out NDOL already, up too big to risk it here

[charthawk]

NDOL, finally moving nicely today

[charthawk]

lol...man unreal, this board is a curse

[charthawk]

NECX chart, hope this breaks the funk...lol...picked up some @ the close today, been making a killing daytrading, but the swing trades not doing so well

breaks .364 res, next res. is .45

[charthawk]

yikes, seems like most of what i post on this board lately goes down, ....unreal

[charthawk]

back in NDOL chart , played it the other day from .25-.27 area, it's ready to retest .55 highs imho, accumulating under .49 area

[charthawk]

in HOMS chart here on pullback 6.92-6.95

should be nice swing trade on pattern chart break here

[charthawk]

out femo, ugh, man gonna stick with momo stuff

[charthawk]

bought FEMO today on chart, break of .05 was huge but then had no steam and was bidwhacked eod today, looking for a nice little move in a swing trade timeframe, no momo on anything today unless it was energy related

[charthawk]

nice man, i've been so busy daytrading ethanol stocks, haven't even been watching much of anything else

[Handles]

VPRO..........on fire.......news must be coming!

[charthawk]

i just sold out RSHN, chart scaring me here

[charthawk]

if it can break .01, we should see .02 imho, that would be next res. point, .02 has always been my longer term target on it since I first entered. We are forming a handle off that saucer, we also have an intraday C&H formed, .008 and then .01 are the breaking points right now, just needs alot more volume, volume slows sometimes before breakouts though while the stock is consolidating

[tiger_rawrrr]

RSHN also has a huge saucer formed from January 2005. It looks like we are in the handle of that to me with a potentially huge breakout after $0.01. Do you have an opinion on that larger pattern? Any long term targets? TIA

[charthawk]

still holding large RSHN position, needs the big volume to come back, chart consolidating nicely in this range, has formed and intraday c&h, have to see what that does

[charthawk]

been doing alot of otc daytrading last few weeks, so I haven't had much time to focus on swing trades, as the market shifts into the summer and the otc dies down, I will be swinging more stuff on the naz and nyse

[charthawk]

accumulating ADVC here while it's quiet, seems to have found a nice bottom again

[charthawk]

RSHN nice today, accumualted a ton over last few days

[charthawk]

scratch UGHO..grrrrr

[charthawk]

forgot the convention pr, also check the form 4's, lots of insider buying last month




Endovasc to Attend BIO 2006 Annual International Convention


By BusinessWire
Last Update: 3/22/2006 9:00:11 AM Data provided by

MONTGOMERY, Texas, Mar 22, 2006 (BUSINESS WIRE) -- Endovasc, Inc. - (EVSC) a Business Development Company focused on acquiring and investing in innovative drug development in the areas of cardiovascular and metabolic medicine, announced today that the Company's President and CEO, Diane Dottavio PhD, will be attending the BIO 2006 Annual International Convention in Chicago on April 9-12, 2006.

BIO, the Biotechnology Industry Organization, is the industry's largest trade organization bringing together thousands of people from around the world representing every aspect of the biotech community. The annual BIO convention attracts top executives, policy makers, members of national and international media, scientists, academicians, and other members of the worldwide biotechnology industry. The convention has experienced significant annual growth in attendance since its inception and the BIO 2006 is set to be the largest yet, with over 1600 exhibiting companies and organizations and over 18,000 expected attendees.

"Endovasc has recently submitted a Phase IIIa clinical trial protocol of its lead drug candidate, Liprostin(TM), for the treatment of intermittent claudication, a symptom of peripheral arterial disease. The BIO 2006 Convention presents a great opportunity for the Company to discuss its latest developments. We feel strongly that Liprostin(TM) can become the standard of care for patients with intermittent claudication, a chronic and painful condition that most frequently goes untreated due to a lack of treatment options. This event provides an excellent platform for the Company to network with industry peers and discuss our upcoming trial," commented Dr. Dottavio.

About Endovasc, Inc.

Endovasc, Inc., established in 1996, is a Business Development Company focused on acquiring and investing in innovative drug development in the areas of cardiovascular and metabolic medicine. Endovasc's subsidiaries include: Liprostin Inc., which holds the intellectual property for a liposomal based treatment to increase circulation and reduce leg pain in patients suffering from vascular disease; Nutraceutical Development Corporation which has an agreement in place with an innovative product development company to commercialize its muscle mass enhancing product; and Prostent, a stent coating technology.

For more information about Endovasc, please visit www.endovasc.com.

Safe Harbor: Except for the historical information contained herein, this news release contains forward-looking statements that involve risk and uncertainties, including clinical results, the timely availability and acceptance of new products, the impact of competitive products and pricing, the availability of funding from partners or capital markets, and the management of growth, as well as the other risks detailed from time to time in Endovasc's Exchange Commission (SEC) Filings, including the company's Annual Report on Form 10-KSB, and quarterly reports on Form 10-QSB.

SOURCE: Endovasc, Inc.

[charthawk]

in EVSC starter .047-.048, accumulate under .05 imho, will be at BIO convention starting on the 9th, should get some nice exposure, plus chart is consolidated and ready for move back up here